Influence of Medical Comorbidities on the Presentation and Outcomes of Stage I-III Non–Small-Cell Lung Cancer

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 48.8K citations

Prognostic Assessment, Longitudinal Studies, Prognostic Comorbidity +11

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

New England Journal of Medicine · 2011 · 10.7K citations · Full text

Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

Laura F. Hutchins, Joseph M. Unger, John J. Crowley et al. · New England Journal of Medicine · 1999 · 2.2K citations

Prognostic Importance of Comorbidity in a Hospital-Based Cancer Registry

Jay F. Piccirillo · JAMA · 2004 · 1.2K citations

Racial Differences in the Treatment of Early-Stage Lung Cancer

Peter B. Bach, Laura D. Cramer, Joan L. Warren et al. · New England Journal of Medicine · 1999 · 1K citations · Full text